(Q36928394)

17 August 2017

1 reference

title

Human interleukin-4: an immunomodulator with potential therapeutic applications (English)

1 reference

17 August 2017

Human interleukin-4: An immunomodulator with potential therapeutic applications (English)

1 reference

https://api.crossref.org/works/10.1016/0955-2235(91)90012-S

21 November 2022

author name string

D. W. Maher

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1777599

21 November 2022

I. Davis

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1777599

21 November 2022

A. W. Boyd

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1777599

21 November 2022

G. Morstyn

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1777599

21 November 2022

language of work or name

1 reference

1 January 1991

1 reference

full work available at URL

17 August 2017

https://api.elsevier.com/content/article/PII:095522359190012S?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0955-2235(91)90012-S

https://api.elsevier.com/content/article/PII:095522359190012S?httpAccept=text/plain

21 November 2022

1 reference

https://api.crossref.org/works/10.1016/0955-2235(91)90012-S

Progress in growth factor research

21 November 2022

published in

1 reference

17 August 2017

volume

3

1 reference

17 August 2017

issue

1

1 reference

17 August 2017

page(s)

43-56

1 reference

Therapy of chronic myelogenous leukemia: chemotherapy and interferons

17 August 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0955-2235(91)90012-S

The impact of colony stimulating factors on cancer chemotherapy

21 November 2022

3

1 reference

https://api.crossref.org/works/10.1016/0955-2235(91)90012-S

Immunotherapy of cancer using interleukin 2: current status and future prospects

21 November 2022

4

1 reference

https://api.crossref.org/works/10.1016/0955-2235(91)90012-S

Identification of a T cell-derived b cell growth factor distinct from interleukin 2.

21 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/0955-2235(91)90012-S

Characterization of the human B cell stimulatory factor 1 receptor

21 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/0955-2235(91)90012-S

Simultaneous production of interleukin 2, interleukin 4 and interferon-gamma by activated human blood lymphocytes

21 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/0955-2235(91)90012-S

Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5, and granulocyte/macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects

21 November 2022

13

1 reference

https://api.crossref.org/works/10.1016/0955-2235(91)90012-S

Human interleukin 4 receptor confers biological responsiveness and defines a novel receptor superfamily

21 November 2022

15

1 reference

https://api.crossref.org/works/10.1016/0955-2235(91)90012-S

Identification of interleukin 4 receptor-associated proteins and expression of both high- and low-affinity binding on human lymphoid cells

21 November 2022

16

1 reference

https://api.crossref.org/works/10.1016/0955-2235(91)90012-S

Independent regulation of interleukin 4 (IL-4)-induced expression of human B cell surface CD23 and IgM: functional evidence for two IL-4 receptors

21 November 2022

17

1 reference

https://api.crossref.org/works/10.1016/0955-2235(91)90012-S

The response of human B cells to interleukin 4 is determined by their stage of activation and differentiation

21 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/0955-2235(91)90012-S

B cell growth-promoting activity of recombinant human interleukin 4

21 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/0955-2235(91)90012-S

Contrasting effects of interleukin 4 (IL-4) on the in vitro proliferation of human B cells is due to the presence of B cell subsets in different activation states

21 November 2022

21

1 reference

https://api.crossref.org/works/10.1016/0955-2235(91)90012-S

Inhibitory influence of IL-4 on human B cell responsiveness

21 November 2022

22

1 reference

https://api.crossref.org/works/10.1016/0955-2235(91)90012-S

Dual effects of interleukin 4 on antigen-activated human B cells: induction of proliferation and inhibition of interleukin 2-dependent differentiation

21 November 2022

23

1 reference

https://api.crossref.org/works/10.1016/0955-2235(91)90012-S

The role of interleukin 4 in specific antibody responses by human B cells

21 November 2022

24

1 reference

https://api.crossref.org/works/10.1016/0955-2235(91)90012-S

Long-Term Human B Cell Lines Dependent on Interleukin-4 and antibody to CD40

21 November 2022

26

1 reference

https://api.crossref.org/works/10.1016/0955-2235(91)90012-S

Mechanism of antigen-driven selection in germinal centres

21 November 2022

29

1 reference

https://api.crossref.org/works/10.1016/0955-2235(91)90012-S

The inductive effect of interleukin-4 on IgG4 and IgE synthesis in human peripheral blood lymphocytes

21 November 2022

31

1 reference

https://api.crossref.org/works/10.1016/0955-2235(91)90012-S

IgE synthesis by chronic lymphocytic leukemia cells

21 November 2022

32

1 reference

https://api.crossref.org/works/10.1016/0955-2235(91)90012-S

Human B cell clones can be induced to proliferate and to switch to IgE and IgG4 synthesis by interleukin 4 and a signal provided by activated CD4+ T cell clones

21 November 2022

33

1 reference

https://api.crossref.org/works/10.1016/0955-2235(91)90012-S

CD40 and IgE: synergism between anti-CD40 monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B cells

21 November 2022

34

1 reference

https://api.crossref.org/works/10.1016/0955-2235(91)90012-S

Modulation of IL-4-induced human IgE production in vitro by IFN-gamma and IL-5: the role of soluble CD23 (s-CD23).

21 November 2022

35

1 reference

https://api.crossref.org/works/10.1016/0955-2235(91)90012-S

Glucocorticoids increase the synthesis of immunoglobulin E by interleukin 4-stimulated human lymphocytes

21 November 2022

38

1 reference

https://api.crossref.org/works/10.1016/0955-2235(91)90012-S

IL-4 inhibits the expression of IL-8 from stimulated human monocytes

21 November 2022

45

1 reference

https://api.crossref.org/works/10.1016/0955-2235(91)90012-S

Contrasting effects of interferon-gamma and interleukin-4 on the interleukin-6 activity of stimulated human monocytes

21 November 2022

46

1 reference

https://api.crossref.org/works/10.1016/0955-2235(91)90012-S

Effect of recombinant human interleukin 4 on human monocyte activity

21 November 2022

48

1 reference

https://api.crossref.org/works/10.1016/0955-2235(91)90012-S

Augmentation of glucocorticoid action on human monocytes by interleukin-4

21 November 2022

49

1 reference

https://api.crossref.org/works/10.1016/0955-2235(91)90012-S

Interleukin 4 induces interleukin 6 production by endothelial cells: synergy with interferon-gamma

21 November 2022

51

1 reference

https://api.crossref.org/works/10.1016/0955-2235(91)90012-S

Growing human B-cell precursors in vitro: the continuing challenge

21 November 2022

57

1 reference

https://api.crossref.org/works/10.1016/0955-2235(91)90012-S

IL-4 induces allergic-like inflammatory disease and alters T cell development in transgenic mice.

21 November 2022

58

1 reference

https://api.crossref.org/works/10.1016/0955-2235(91)90012-S

Interleukin 4 expressed in situ selectively alters thymocyte development

21 November 2022

59

1 reference

https://api.crossref.org/works/10.1016/0955-2235(91)90012-S

Interleukin 4 induces CD4+/CD8− to CD8+/CD4− transformation of human neonatal T cells by way of a double positive intermediate

21 November 2022

60

1 reference

https://api.crossref.org/works/10.1016/0955-2235(91)90012-S

A role for interleukin 4 in the differentiation of mature T cell receptor gamma/delta + cells from human intrathymic T cell precursors

21 November 2022

61

1 reference

https://api.crossref.org/works/10.1016/0955-2235(91)90012-S

Receptor-directed focusing of lymphokine release by helper T cells

21 November 2022

64

1 reference

https://api.crossref.org/works/10.1016/0955-2235(91)90012-S

Heterogeneity in lymphokine profiles of CD4+ and CD8+ T cells and clones activated in vivo and in vitro

21 November 2022

65

1 reference

https://api.crossref.org/works/10.1016/0955-2235(91)90012-S

Differential production of IL-2 and IL-4 mRNA in vivo after primary sensitization

21 November 2022

66

1 reference

https://api.crossref.org/works/10.1016/0955-2235(91)90012-S

Interleukin 4 induces selective production of interleukin 6 from normal human B lymphocytes

21 November 2022

68

1 reference

https://api.crossref.org/works/10.1016/0955-2235(91)90012-S

Murine interleukin-4 displays potent anti-tumor activity in vivo

21 November 2022

69

1 reference

https://api.crossref.org/works/10.1016/0955-2235(91)90012-S

Retroviral interleukin 4 gene transfer into an interleukin 4-dependent cell line results in autocrine growth but not in tumorigenicity

21 November 2022

71

1 reference

https://api.crossref.org/works/10.1016/0955-2235(91)90012-S

Interleukin 4 promotes the growth of tumor-infiltrating lymphocytes cytotoxic for human autologous melanoma

21 November 2022

73

1 reference

https://api.crossref.org/works/10.1016/0955-2235(91)90012-S

Interleukin 4 counteracts the interleukin 2-induced proliferation of monoclonal B cells

21 November 2022

74

1 reference

https://api.crossref.org/works/10.1016/0955-2235(91)90012-S

Human recombinant IL-4 induces activated B lymphocytes to produce IgG and IgM

21 November 2022

86

1 reference

https://api.crossref.org/works/10.1016/0955-2235(91)90012-S

Increased expression of surface IgM but not IgD or IgG on human B cells in response to IL-4

21 November 2022

87

1 reference

https://api.crossref.org/works/10.1016/0955-2235(91)90012-S

Human recombinant interleukin 4 induces Fc epsilon receptors (CD23) on normal human B lymphocytes.

21 November 2022

88

1 reference

https://api.crossref.org/works/10.1016/0955-2235(91)90012-S

Human B cell proliferation in response to IL-4 is associated with enhanced production of B cell-derived growth factors

21 November 2022

90

1 reference

https://api.crossref.org/works/10.1016/0955-2235(91)90012-S

Recombinant interleukin-4 promotes expression of the CD25 (Tac) antigen at the plasma membrane of high-density human tonsillar B lymphocytes

21 November 2022

91

1 reference

https://api.crossref.org/works/10.1016/0955-2235(91)90012-S

IL-4 blocks the up-regulation of IL-2 receptors induced by IL-2 in normal human B cells

21 November 2022

92

1 reference

https://api.crossref.org/works/10.1016/0955-2235(91)90012-S

Human interleukin 4 down-regulates the surface expression of CD5 on normal and leukemic B cells

21 November 2022

93

1 reference

https://api.crossref.org/works/10.1016/0955-2235(91)90012-S

Isolation and characterization of a human interleukin cDNA clone, homologous to mouse B-cell stimulatory factor 1, that expresses B-cell- and T-cell-stimulating activities

21 November 2022

94

1 reference

https://api.crossref.org/works/10.1016/0955-2235(91)90012-S

Modulation of phenotypic and functional properties of human peripheral blood monocytes by IL-4

21 November 2022

95

1 reference

https://api.crossref.org/works/10.1016/0955-2235(91)90012-S

Human recombinant interleukin 4 induces Fc epsilon R2/CD23 on normal human monocytes

21 November 2022

96

1 reference

https://api.crossref.org/works/10.1016/0955-2235(91)90012-S

21 November 2022

Identifiers

1 reference

17 August 2017

1 reference